Leap Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
GILEAD SCIENCES, INC. | 08/14/2025 | 5.32 M | $1.58 M | 0.00% | 12.89% |
683 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 1.44 M | $428.77 K | -0.40% | 3.50% |
ACADIAN ASSET MANAGEMENT LLC | 08/07/2025 | 1.24 M | $365.00 K | -3.39% | 3.00% |
VANGUARD GROUP INC | 08/11/2025 | 1.16 M | $344.72 K | -1.27% | 2.81% |
HIGHTOWER ADVISORS, LLC | 08/11/2025 | 1.10 M | $325.66 K | 2,071.98% | 2.66% |
MONACO ASSET MANAGEMENT SAM | 08/07/2025 | 1.05 M | $311.75 K | 0.00% | 2.54% |
SIMPLIFY ASSET MANAGEMENT INC. | 08/07/2025 | 857.36 K | $254.55 K | -9.84% | 2.08% |
KEY CLIENT FIDUCIARY ADVISORS, LLC | 07/09/2025 | 343.86 K | $102.09 K | -11.54% | 0.83% |
GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 312.19 K | $92.74 K | 2.66% | 0.76% |
STATE STREET CORP | 08/14/2025 | 125.61 K | $37.30 K | 0.00% | 0.30% |
BLACKROCK, INC. | 08/12/2025 | 125.23 K | $37.18 K | -37.90% | 0.30% |
UBS GROUP AG | 08/14/2025 | 122.20 K | $36.29 K | 12.73% | 0.30% |
CITADEL ADVISORS LLC | 08/14/2025 | 74.93 K | $22.25 K | 100.00% | 0.18% |
NORTHERN TRUST CORP | 08/13/2025 | 61.61 K | $18.29 K | 0.00% | 0.15% |
08/14/2025 | 59.97 K | $17.80 K | 100.00% | 0.15% | |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 48.77 K | $14.48 K | -83.19% | 0.12% |
BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 08/04/2025 | 44.21 K | $13.13 K | 51.36% | 0.11% |
LPL FINANCIAL LLC | 08/12/2025 | 43.51 K | $12.92 K | -18.46% | 0.11% |
TWO SIGMA ADVISERS, LP | 08/14/2025 | 41.28 K | $12.26 K | 100.00% | 0.10% |
VIRTU FINANCIAL LLC | 08/12/2025 | 40.38 K | $12.00 K | 100.00% | 0.10% |
ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2025 | 39.93 K | $11.85 K | -64.03% | 0.10% |
CITADEL ADVISORS LLC | 08/14/2025 | 36.80 K | $10.93 K | -41.40% | 0.09% |
DRW SECURITIES, LLC | 08/14/2025 | 28.16 K | $8.36 K | 0.00% | 0.07% |
BAIRD FINANCIAL GROUP, INC. | 08/13/2025 | 20.00 K | $5.94 K | 0.00% | 0.05% |
XTX TOPCO LTD | 08/12/2025 | 14.03 K | $4.17 K | 100.00% | 0.03% |
TWO SIGMA INVESTMENTS, LP | 08/14/2025 | 13.90 K | $4.13 K | 8.25% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 12.80 K | $3.84 K | -9.86% | 0.03% |
BLAIR WILLIAM & CO/IL | 07/24/2025 | 10.00 K | $2.97 K | 0.00% | 0.02% |
SIMPLEX TRADING, LLC | 08/05/2025 | 5.15 K | $1.00 K | 100.00% | 0.01% |
CNB BANK | 07/31/2025 | 5.00 K | $1.49 K | 66.67% | 0.01% |
RAYMOND JAMES FINANCIAL INC | 08/14/2025 | 4.58 K | $1.36 K | 100.00% | 0.01% |
GROUP ONE TRADING, L.P. | 08/14/2025 | 3.81 K | $1.13 K | 15.09% | 0.01% |
ADVISOR GROUP HOLDINGS, INC. | 08/13/2025 | 1.88 K | $5.42 K | 0.00% | 0.00% |
CIBC PRIVATE WEALTH GROUP, LLC | 08/12/2025 | 1.50 K | $445 | 0.00% | 0.00% |
HUNTINGTON NATIONAL BANK | 08/05/2025 | 1.00 K | $297 | 0.00% | 0.00% |
FARTHER FINANCE ADVISORS, LLC | 07/11/2025 | 1.00 K | $297 | 0.00% | 0.00% |
MORGAN STANLEY | 08/15/2025 | 634 | $188 | -47.39% | 0.00% |
BANK OF AMERICA CORP /DE/ | 08/14/2025 | 320 | $95 | 23.55% | 0.00% |
JPMORGAN CHASE & CO | 08/12/2025 | 227 | $67 | 0.00% | 0.00% |
ALLWORTH FINANCIAL LP | 08/07/2025 | 135 | $41 | 17.39% | 0.00% |
TOMPKINS FINANCIAL CORP | 07/10/2025 | 120 | $36 | 0.00% | 0.00% |
FINANCIAL MANAGEMENT PROFESSIONALS, INC. | 07/15/2025 | 20 | $6 | 0.00% | 0.00% |
CALDWELL SUTTER CAPITAL, INC. | 07/11/2025 | 4 | $1 | 0.00% | 0.00% |
BARCLAYS PLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
ROYAL BANK OF CANADA | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/13/2025 | 0 | $0 | -100.00% | 0.00% |
BAKER BROS. ADVISORS LP | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
LAURION CAPITAL MANAGEMENT LP | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
CITADEL ADVISORS LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
JANE STREET GROUP, LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
Leap Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 54 institutional investors and hedge funds held shares of Leap Therapeutics, Inc.. The most heavily invested institutionals were:
GILEAD SCIENCES, INC.: 5.32 M
683 Capital Management, LLC: 1.44 M
ACADIAN ASSET MANAGEMENT LLC: 1.24 M
VANGUARD GROUP INC: 1.16 M
HighTower Advisors, LLC: 1.1 M
Monaco Asset Management SAM: 1.05 M
33.34% of Leap Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 14.14 M shares in the last 24 months. This purchase volume represents approximately $3.96 M in transactions.